Anna L Ameli, NP
Nurse Practitioner · San Fransisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Anna L Ameli’s office at (415) 426-7859 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C20633 · Deceased
Licence status: Deceased · since 1959 · Duke University School of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$7,803
Pharmacies billed $7,803 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 75) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
60 generic and 15 brand-name prescriptions · $7,803 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 19 | $783 | $41 |
| Progesterone | 15 | $349 | $23 |
Year by year
| 2024 | 75 | 41 | 0% (0) | 20% | $7,803 |
| 2023 | 16 | 14 | 0% (0) | None | $1,998 |
| 2022 | 74 | 41 | 0% (0) | 36% | $15,601 |
| 2021 | 58 | 32 | 0% (0) | 24% | $5,602 |
| 2020 | 66 | 28 | 0% (0) | 41% | $10,248 |
| 2019 | 18 | 13 | 0% (0) | None | $2,437 |
| 2018 | 19 | None | 0% (0) | None | $1,755 |
| 2016 | 22 | None | 64% (14) | None | $712 |
| 2015 | 276 | 48 | 73% (200) | 14% | $28,736 |
| 2014 | 379 | 65 | 63% (240) | 14% | $37,896 |
| 2013 | 589 | 108 | 67% (397) | 21% | $52,622 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Premarin | 11 | $4,872 | $443 |
| Estradiol | 31 | $2,949 | $95 |
2021: 1 drug
| Estradiol | 21 | $905 | $43 |
2020: 2 drugs
| Premarin | 14 | $2,983 | $213 |
| Estradiol | 14 | $1,160 | $83 |
2015: 5 drugs
| Oxycontin | 22 | $14,036 | $638 |
| Morphine Sulfate Er | 24 | $3,162 | $132 |
| Hydrocodone-Acetaminophen | 80 | $2,781 | $35 |
| Oxycodone-Acetaminophen | 25 | $2,150 | $86 |
| Gabapentin | 22 | $324 | $15 |
2014: 12 drugs
| Oxycontin | 17 | $7,544 | $444 |
| Morphine Sulfate Er | 37 | $5,909 | $160 |
| Lyrica | 17 | $4,457 | $262 |
| Fentanyl | 16 | $2,879 | $180 |
| Hydrocodone-Acetaminophen | 104 | $2,684 | $26 |
| Oxycodone-Acetaminophen | 18 | $1,868 | $104 |
| Hydromorphone | 14 | $1,434 | $102 |
| Oxycodone | 15 | $875 | $58 |
| Carisoprodol | 27 | $742 | $27 |
| Gabapentin | 23 | $518 | $23 |
| Tizanidine | 13 | $202 | $16 |
| Zolpidem | 15 | $168 | $11 |
2013: 16 drugs
| Oxycontin | 30 | $15,444 | $515 |
| Opana Er | 11 | $5,521 | $502 |
| Morphine Sulfate Er | 53 | $4,924 | $93 |
| Fentanyl | 26 | $4,303 | $166 |
| Lyrica | 15 | $3,730 | $249 |
| Hydrocodone-Acetaminophen | 131 | $3,360 | $26 |
| Hydromorphone | 24 | $2,478 | $103 |
| Oxycodone Hcl-Acetaminophen | 47 | $2,446 | $52 |
| Oxycodone | 17 | $607 | $36 |
| Carisoprodol | 30 | $505 | $17 |
| Gabapentin | 24 | $449 | $19 |
| Morphine Sulfate | 22 | $389 | $18 |
| Tizanidine | 13 | $320 | $25 |
| Sumatriptan | 11 | $301 | $27 |
| Zolpidem | 24 | $140 | $6 |
| Diazepam | 20 | $105 | $5 |
Money from drug and device companies
$257 in 2025
| 2025 | 6 | 13 | None | $257 |
| 2024 | 5 | 8 | None | $187 |
| 2023 | 3 | 5 | None | $104 |
| 2022 | 8 | 11 | None | $216 |
| 2021 | 6 | 19 | None | $275 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biogen | Zurzuvae | $90 | 3 payments
|
| Mayne Pharma Commercial | None | $48 | 4 payments
|
| CooperSurgical | Paragard T 380a | $40 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $34 | 1 payment
|
| Evofem Biosciences | Phexxi | $32 | 2 payments
|
| Organon | Nexplanon | $13 | 1 payment
|
See all 13 published payments
| CooperSurgical | Meals · 2025-07-10 | Paragard T 380a | $21 |
| CooperSurgical | Meals · 2025-05-14 | Paragard T 380a | $18 |
| Exact Sciences | Meals · 2025-05-05 | Cologuard Collection Kit | $34 |
| Biogen | Meals · 2025-04-30 | Zurzuvae | $30 |
| Mayne Pharma Commercial | Meals · 2025-04-08 | None | $3 |
| Mayne Pharma Commercial | Meals · 2025-03-27 | None | $20 |
| Evofem Biosciences | Meals · 2025-03-26 | Phexxi | $16 |
| Biogen | Meals · 2025-03-18 | Zurzuvae | $30 |
| Organon | Meals · 2025-03-10 | Nexplanon | $13 |
| Mayne Pharma Commercial | Meals · 2025-03-05 | None | $3 |
| Biogen | Meals · 2025-02-26 | Zurzuvae | $30 |
| Mayne Pharma Commercial | Meals · 2025-02-18 | None | $22 |
| Evofem Biosciences | Meals · 2025-01-30 | Phexxi | $17 |
See earlier years (2024, 2023, 2022, 2021)
2024: $187
| Becton Dickinson and | None | $53 | 2 payments
|
| Biogen | Zurzuvae | $44 | 2 payments
|
| Organon | Nexplanon | $40 | 2 payments
|
| Abbvie | Liletta | $29 | 1 payment
|
| Pfizer | Premarin | $21 | 1 payment
|
2023: $104
| Abbvie | Liletta | $62 | 3 payments
|
| Shield Therapeutics | Accrufer | $22 | 1 payment
|
| Pfizer | Premarin | $20 | 1 payment
|
2022: $216
| Abbvie | Liletta | $46 | 2 payments
|
| Organon | None | $43 | 2 payments
|
| Evofem Biosciences | Phexxi | $39 | 2 payments
|
| CooperSurgical | Paragard | $22 | 1 payment
|
| Daiichi Sankyo | Injectafer | $21 | 1 payment
|
| Mayne Pharma | None | $15 | 1 payment
|
| Pfizer | Premarin | $15 | 1 payment
|
| Avion Pharmaceuticals | Divigel | $14 | 1 payment
|
2021: $275
| TherapeuticsMD | Annovera | $123 | 12 payments
|
| AbbVie | Oriahnn | $56 | 2 payments
|
| Mylan Pharmaceuticals | Xulane | $42 | 2 payments
|
| CooperSurgical | Paragard | $19 | 1 payment
|
| Pfizer | Premarin | $18 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $16 | 1 payment
|
Professional record
- NPI
- 1720327299
- Licence
- CA 20633, CA 793861California C20633: Deceased
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 2100 Webster St, Suite 518, San Fransisco, CA, 94115
- NPI first listed
- 2013-02-04
- NPI last updated
- 2017-02-20
This is when the NPI record was last certified, not a medical board exam.